Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Zhilin Qu"

  • Modify Search
  • Create Alert
  • Save Search

11 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 07/22/2017
e.g., 07/22/2017
Format Results
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 1.
    Figure 1.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Hypokalemia-induced VF in adult isolated Langendorff rabbit (A) and rat (B...
    Show More
    Hypokalemia-induced VF in adult isolated Langendorff rabbit (A) and rat (B) hearts exposed to 2.7 mmol/L [K]o. Left, Sinus rhythm during normokalemia, as recorded with a pseudo-ECG, bipolar electrograms from the left atrium (LA) and right ventricle (RV), and an epicardial intracellular microelectrode (ME). Middle and Right, Onset of EAD-mediated triggered activity (*) from sinus rhythm during hypokalemia. Arrows in B indicate DADs. DADs indicates delayed afterdepolarizations; EAD, early afterdepolarization; and VF, ventricular fibrillation.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 2.
    Figure 2.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Optical action potential recordings and activation maps during EAD-mediated triggered activity in an isolate...
    Show More
    Optical action potential recordings and activation maps during EAD-mediated triggered activity in an isolated-perfused rat heart exposed to hypokalemia (2.7 mmol/L [K]). A, Optical voltage fluorescence (FV) traces from 4 adjacent sites labeled 1 to 4 in B, illustrating 2 runs of EAD-mediated triggered activity (b1–b13) arising spontaneously from sinus rhythm (beats S1 and S6). B, Optical voltage fluorescence snapshots corresponding to the labeled beats in A. C, Isochronal activation maps of a sinus beat (S6) and the subsequent triggered beat (b7) indicating the different sites of origin. EAD indicates early afterdepolarization.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 3.
    Figure 3.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    K dependence of hypokalemia-induced VT/VF in isolated rabbit hearts, in the absence and presence of dofetili...
    Show More
    K dependence of hypokalemia-induced VT/VF in isolated rabbit hearts, in the absence and presence of dofetilide. A, When extracellular K concentration was lowered from the control value of 5.4 mmol/L to 4.0, 3.5, 2.7, 2.0, or 1.0 mmol/L, the incidence of VT/VF within 90 minutes progressively increased to 100% at 2.0 and 1.0 mmol/L. Data show median and 83% CI for the number of hearts indicated in parentheses, in the absence (black circles) or presence (red circles) of 1 μmol/L dofetilide. The percentage of hearts developing VT/VF at 2.7 mmol/L [K] was significantly increased by dofetilide (P=0.03). Curves are fits to a Hill equation in the absence (black curve) and presence of dofetilide (red curve). B, Kaplan–Meier survival curves comparing time to onset of VT/VF, with 83% CI indicated by shading (solid lines, without dofetilide; dashed line, with dofetilide). Rate of VT/VF onset was significantly faster at 1.0 and 2.0 mmol/L [K] than at higher [K] (P=0.0002–0.002), and significantly faster at 2.7 mmol/L [K] in the presence of dofetilide than in its absence (P=0.02). CI indicates confidence interval; VF, ventricular fibrillation; and VT, ventricular tachycardia.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 4.
    Figure 4.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Suppression of hypokalemia-induced VF by CaMKII inhibition or late INa blockade. Represe...
    Show More
    Suppression of hypokalemia-induced VF by CaMKII inhibition or late INa blockade. Representative ECG and RV electrograms from isolated rabbit ventricles at the times indicated after reducing [K]o from 5.4 to 2.0 mmol/L. A, No drug, illustrating the spontaneous transition from sinus rhythm to VT/VF after 10 minutes. B, KN-93 (1 μmol/L), illustrating maintenance of sinus rhythm after 30 minutes. C, Same heart as in B, 3 minutes after replacing KN-93 with KN-92 (1 μmol/L), illustrating spontaneous onset of VT/VF. D, GS-967 (1 μmol/L), illustrating maintenance of sinus rhythm after 30 minutes. E, Same heart as in D, 38 minutes after washing out GS-967, illustrating onset of spontaneous VT/VF. CaMKII indicates Ca-calmodulin kinase II; RV, right ventricle; VF, ventricular fibrillation; and VT, ventricular tachycardia.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 5.
    Figure 5.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Basal (autophosphorylated) tissue CaMKII activity level, expressed as percentage of maximal Ca/CaM-stimulate...
    Show More
    Basal (autophosphorylated) tissue CaMKII activity level, expressed as percentage of maximal Ca/CaM-stimulated CaMKII activity, in isolated rabbit ventricular tissue arterially perfused with 5.4 mmol/L or 2.7 mmol [K]o for 30 minutes. Individual data points, median, 95% confidence intervals, and P value are indicated. For 2.7 mmol/L data, open circles indicate hearts in which no VT/VF occurred during hypokalemia (2 hearts), and open squares indicate hearts in which transient (1- to 2-minute episodes in 2 hearts) or sustained VT/VF developed (1 heart) during hypokalemia. CaMKII indicates Ca-calmodulin kinase II; VF, ventricular fibrillation; and VT, ventricular tachycardia.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 6.
    Figure 6.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Suppression of hypokalemia-induced EADs by CaMKII inhibition and late INa blockade in is...
    Show More
    Suppression of hypokalemia-induced EADs by CaMKII inhibition and late INa blockade in isolated patch-clamped rabbit ventricular myocytes. Membrane voltage (Vm) traces during pacing at PCL 6 s. Top to bottom traces: A, [K]o=5.4 mmol/L; 2.7 mmol/L; 2.7 mmol/L+1 μmol/L KN-92; 2.7 mmol/L+1 μmol/L KN-92. B, [K]o=5.4 mmol/L+AIP; 2.7 mmol/L+AIP (dialyzed for 30 minutes). C, [K]o=5.4 mmol/L; 2.7 mmol/L; 2.7 mmol/L; 2.7 mmol/L+1 μmol/L GS-967 (bottom). Right panels show superimposed action potentials under the various conditions for A through C. AIP indicates autocamptide-2–related inhibitor peptide; CaMKII, Ca-calmodulin kinase II; EAD, early afterdepolarization; and PCL, pacing cycle length.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 7.
    Figure 7.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Effects of hypokalemia on membrane voltage (Vm), [Ca]i, and [Na]i in the ra...
    Show More
    Effects of hypokalemia on membrane voltage (Vm), [Ca]i, and [Na]i in the rabbit ventricular AP model paced at a CL of 1 s. A, Vm at various times corresponding to B, for [K]o=5.4 mmol/L (blue traces); [K]o=2.7 mmol/L (red traces); and [K]o=2.7 mmol/L with CaMKII signaling disabled (green traces). B and C, Corresponding time course of changes in [Ca]i (B) and [Na]i (C). [Ca]i and [Na]i accelerate rapidly with the onset of EADs, and systolic [Ca]i then transiently decreases when EADs transition to repolarization failure. D, Time to onset of the first EAD vs level of [K]o, with normal IKr (black) or IKr blocked (red) to simulate the effects of dofetilide. CaMKII indicates Ca-calmodulin kinase II; CL, cycle length; and EAD, early afterdepolarization.
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    View table
    Table.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Effects of Simulated Hypokalemia on [Na]i, Mean [Ca]i (averaged throughout the cardiac...
    Show More
    Effects of Simulated Hypokalemia on [Na]i, Mean [Ca]i (averaged throughout the cardiac cycle), Late INa (as a surrogate index of CaMKII activity), APD (ms), and EAD Development in the Rabbit Ventricular AP Model Under Various Conditions
    Show Less
  • You have access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian, James N. Weiss
    Circulation October 2015, 132 (16) 1528-1537; DOI: https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Figure 8.
    Figure 8.
    By Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Schema of positive feedback loops (red and blue arrows) promoting intracellular Na and Ca overload, CaMKII a...
    Show More
    Schema of positive feedback loops (red and blue arrows) promoting intracellular Na and Ca overload, CaMKII activation, and EADs during hypokalemia. The potentiation of the blue positive feedback loop by class III antiarrhythmic (AA) drugs such as dofetilide is also shown. APD indicates action potential duration; CaMKII, Ca-calmodulin kinase II; EAD, early afterdepolarization; and INaK, Na-K pump current.
    Show Less
  • You have accessRestricted access
    Molecular Basis of Hypokalemia-Induced Ventricular FibrillationCLINICAL PERSPECTIVE
    Arash Pezhouman, Neha Singh, Zhen Song, Michael Nivala, Anahita Eskandari, Hong Cao, Aneesh Bapat, Christopher Y. Ko, Thao P. Nguyen, Zhilin Qu, Hrayr S. Karagueuzian and James N. Weiss
    Circulation. 2015;132:1528-1537, originally published August 12, 2015
    https://doi.org/10.1161/CIRCULATIONAHA.115.016217
    Download PDF

Pages

  • 1
  • 2
  • Next Page
Back to top

Selected Facets

Selected Facets

  • Electrophysiology (Article Type)

Publication Date

Publication date

  • 2013-2016 10
  • 2003-2007 1

Subject

Subject

  • Animal models of human disease 1
  • Arrythmias-basic studies 11

Content Type

Resource Type

  • Articles 2
  • Tables & Figures 9
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured